x

Support HDYO

HDYO is the only organization who focus solely on supporting young people impacted by HD around the world. Will you help us?

Donate
x
<span class="translation_missing" title="translation missing: en.hdyo.land.loading">Loading</span>
X
 Home Language and Accessibility What is HD? New to HD? Find Resources Research Ask for Help About HDYO News Videos HD Information In Other Languages PDF Resources Join Mailing List HDYO Ambassadors Social Media Kids Teens Young Adults Parents and Family JoHD Friends Professionals DONATE! Privacy Contact Us

Research Video Series: SURVEYOR opens the door

August 30, 2024

Huntington's Disease Youth Organization

HDYO has more information about HD available for young people, parents and professionals on our site:

www.hdyo.org

This edition of the HDYO Research Video Series, we look at the article, SURVEYOR opens the door for drugs that treat cognition. Sage Therapeutics announced results from SURVEYOR, a trial that looked at cognitive changes in people with HD, and tested short-term safety of dalzanemdor. The study was small but met key goals, and additional trials are in progress.

Read the Complete Article

The HDYO Research Video Series is sponsored by Roche, Sage Therapeutics, Teva Pharmaceutical, uniQure, Wave Life Sciences, Griffin Foundation and Neurocrine Biosciences.

Our content is split into different groups. Choose the group that best describes your needs for more information on HD.

Kids Teens Young Adults Parents and Family JoHD Friends Professionals